Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease

Restricted access

OBJECT

Peritumoral cysts are frequently associated with CNS hemangioblastomas and often underlie neurological morbidity and mortality. To determine their natural history and clinical impact, the authors prospectively analyzed hemangioblastoma-associated peritumoral cysts in patients with von Hippel-Lindau (VHL) disease.

METHODS

Patients with VHL disease who had 2 or more years of follow-up and who were enrolled in a prospective study at the National Institutes of Health were included. Serial prospectively acquired laboratory, genetic, imaging, and clinical data were analyzed.

RESULTS

One hundred thirty-two patients (of 225 in the VHL study with at least 2 years of follow-up) had peritumoral cysts that were followed for more than 2 years (total of 292 CNS peritumoral cysts). The mean age at study entrance was 37.4 ± 13.1 years ([mean ± SD], median 37.9, range 12.3–65.1 years). The mean follow-up was 7.0 ± 1.7 years (median 7.3, range 2.1–9.0 years). Over the study period, 121 of the 292 peritumoral cysts (41.4%) became symptomatic. Development of new cysts was associated with a larger number cysts at study enrollment (p = 0.002) and younger age (p < 0.0001). Cyst growth rate was associated with anatomical location (cerebellum cysts grew faster than spine and brainstem cysts; p = 0.0002 and p = 0.0008), younger age (< 35 years of age; p = 0.0006), and development of new neurological symptoms (p < 0.0001). Cyst size at symptom production depended on anatomical location (p < 0.0001; largest to smallest were found, successively, in the cerebellum, spinal cord, and brainstem). The most common location for peritumoral cysts was the cerebellum (184 cysts [63%]; p < 0.0001).

CONCLUSIONS

Peritumoral cysts frequently underlie symptom formation that requires surgical intervention in patients with VHL disease. Development of new cysts was associated with a larger number of cysts at study enrollment and younger age. Total peritumoral cyst burden was associated with germline partial deletion of the VHL gene.

ABBREVIATIONSIQR = interquartile range; ROC = receiver operating characteristic; VHL = von Hippel-Lindau.
Article Information

Contributor Notes

Correspondence Russell R. Lonser, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, 410 W. 10th Ave., Doan Hall N1047, Columbus, OH 43210. email: russell.lonser@osumc.edu.INCLUDE WHEN CITING Published online October 30, 2015; DOI: 10.3171/2015.4.JNS1533.Disclosure The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

© AANS, except where prohibited by US copyright law.

Headings
References
  • 1

    Ammerman JMLonser RRDambrosia JButman JAOldfield EH: Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg 105:2482552006

    • Search Google Scholar
    • Export Citation
  • 2

    Asthagiri ARMehta GUZach LLi XButman JACamphausen KA: Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol 12:80862010

    • Search Google Scholar
    • Export Citation
  • 3

    Berkman RAMerrill MJReinhold WCMonacci WTSaxe-na AClark WC: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:1531591993

    • Search Google Scholar
    • Export Citation
  • 4

    Butman JALinehan WMLonser RR: Neurologic manifestations of von Hippel-Lindau disease. JAMA 300:133413422008

  • 5

    Cockman MEMasson NMole DRJaakkola PChang GWClifford SC: Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275:25733257412000

    • Search Google Scholar
    • Export Citation
  • 6

    Filling-Katz MRChoyke PLOldfield ECharnas LPatronas NJGlenn GM: Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41:41461991

    • Search Google Scholar
    • Export Citation
  • 7

    Gläsker S: Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features. Fam Cancer 4:37422005

    • Search Google Scholar
    • Export Citation
  • 8

    Jagannathan JLonser RRSmith RDeVroom HLOldfield EH: Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 108:2102222008

    • Search Google Scholar
    • Export Citation
  • 9

    Lamiell JMSalazar FGHsia YE: von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 68:1291989

    • Search Google Scholar
    • Export Citation
  • 10

    Lohle PNvan Mameren HZwinderman KHTeepen HLGo KGWilmink JT: On the pathogenesis of brain tumour cysts: a volumetric study of tumour, oedema and cyst. Neuroradiology 42:6396422000

    • Search Google Scholar
    • Export Citation
  • 11

    Lonser RRButman JAHuntoon KAsthagiri ARWu TBakhtian KD: Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg 120:105510622014

    • Search Google Scholar
    • Export Citation
  • 12

    Lonser RRButman JAOldfield EH: Pathogenesis of tumor-associated syringomyelia demonstrated by peritumoral contrast material leakage. Case illustration. J Neurosurg Spine 4:4262006

    • Search Google Scholar
    • Export Citation
  • 13

    Lonser RRGlenn GMWalther MChew EYLibutti SKLinehan WM: von Hippel-Lindau disease. Lancet 361:205920672003

  • 14

    Lonser RRVortmeyer AOButman JAGlasker SFinn MAAmmerman JM: Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol 58:3923992005

    • Search Google Scholar
    • Export Citation
  • 15

    Lundin PPedersen F: Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16:5195281992

  • 16

    Maddock IRMoran AMaher ERTeare MDNorman APayne SJ: A genetic register for von Hippel-Lindau disease. J Med Genet 33:1201271996

    • Search Google Scholar
    • Export Citation
  • 17

    Maher ERYates JRHarries RBenjamin CHarris RMoore AT: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:115111631990

    • Search Google Scholar
    • Export Citation
  • 18

    Mehta GUAsthagiri ARBakhtian KDAuh SOldfield EHLonser RR: Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease. J Neurosurg Spine 12:2332422010

    • Search Google Scholar
    • Export Citation
  • 19

    Melmon KLRosen SW: Lindau’s disease. Review of the literature and study of a large kindred. Am J Med 36:5956171964

  • 20

    Neumann HPEggert HRScheremet RSchumacher MMohadjer MWakhloo AK: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:8989011992

    • Search Google Scholar
    • Export Citation
  • 21

    Neumann HPLips CJHsia YEZbar B: Von Hippel-Lindau syndrome. Brain Pathol 5:1811931995

  • 22

    Richard SCampello CTaillandier LParker FResche F: Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. J Intern Med 243:5475531998

    • Search Google Scholar
    • Export Citation
  • 23

    Richard SChauveau DChrétien YBeigelman CDenys AFendler JP: Renal lesions and pheochromocytoma in von Hippel-Lindau disease. Adv Nephrol Necker Hosp 23:1271994

    • Search Google Scholar
    • Export Citation
  • 24

    Simone CB IILonser RROndos JOldfield EHCamphausen KSimone NL: Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro Oncol 13:103010362011

    • Search Google Scholar
    • Export Citation
  • 25

    Stolle CGlenn GZbar BHumphrey JSChoyke PWalther M: Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:4174231998

    • Search Google Scholar
    • Export Citation
  • 26

    Wanebo JELonser RRGlenn GMOldfield EH: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82942003

    • Search Google Scholar
    • Export Citation
  • 27

    Wind JJBakhtian KDSweet JAMehta GUThawani JPAsthagiri AR: Long-term outcome after resection of brainstem hemangioblastomas in von Hippel-Lindau disease. J Neurosurg 114:131213182011

    • Search Google Scholar
    • Export Citation
  • 28

    Wind JJLonser RR: Management of von Hippel-Lindau disease-associated CNS lesions. Expert Rev Neurother 11:143314412011

TrendMD
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 365 298 28
PDF Downloads 230 161 16
EPUB Downloads 0 0 0
PubMed
Google Scholar